Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.

Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial. Thromb Haemost. 2019 Mar; 119(3):461-466.

View in: PubMed

subject areas

Adult
Adult
Aged
Aged
Anticoagulants
Anticoagulants
Double-Blind Method
Double-Blind Method
Drug Administration Schedule
Drug Administration Schedule
Enoxaparin
Enoxaparin
Factor Xa Inhibitors
Factor Xa Inhibitors
Female
Female
Hemorrhage
Hemorrhage
Humans
Humans
Male
Male
Middle Aged
Middle Aged
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Pyrazoles
Pyrazoles
Pyridones
Pyridones
Risk Assessment
Risk Assessment
Risk Factors
Risk Factors
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
Venous Thromboembolism
Venous Thromboembolism
Warfarin
Warfarin

authors with profiles

Gary E Raskob